Learn About Meibomianitis

What is the definition of Meibomianitis?

Meibomianitis is inflammation of the meibomian glands, a group of oil-releasing (sebaceous) glands in the eyelids. These glands have tiny openings to release oils onto the surface of the cornea.

Save information for later
Sign Up
What are the alternative names for Meibomianitis?

Meibomian gland dysfunction

What are the causes of Meibomianitis?

Any condition that increases the oily secretions of the meibomian glands will allow excess oils to build up on the edges of the eyelids. This allows for the excess growth of bacteria that are normally present on the skin.

These problems can be caused by allergies, hormone changes during adolescence, or skin conditions such as rosacea and acne.

Meibomianitis is often associated with blepharitis, which can cause a buildup of a dandruff-like substance at the base of the eyelashes.

In some people with meibomianitis, the glands will be plugged so that there is less oil being made for the normal tear film. These people often have symptoms of dry eye.

What are the symptoms of Meibomianitis?

Symptoms include:

  • Swelling and redness of eyelid edges
  • Symptoms of dry eye
  • Slight blurring of vision due to excess oil in tears -- most often cleared by blinking
  • Frequent styes
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Meibomianitis?

Standard treatment involves:

  • Carefully cleansing the edges of the lids
  • Applying moist heat to the affected eye

These treatments will usually reduce symptoms in most cases.

Your health care provider may prescribe an antibiotic ointment to apply to the lid's edge.

Other treatments may include:

  • Having an eye doctor perform meibomian gland expression to help clear the glands of secretions.
  • Inserting a small tube (cannula) into each gland opening to wash out thickened oil.
  • Taking tetracycline antibiotics for several weeks.
  • Using LipiFlow, a device that automatically warms the eyelid and helps clear the glands.
  • Taking fish oil to improve the flow of oil from the glands.
  • Using a medicine containing hypochlorous acid, this is sprayed onto the eyelids. This may be particularly useful in people who have rosacea.

You may also need treatment for general skin conditions such as acne or rosacea.

Who are the top Meibomianitis Local Doctors?
Learn about our expert tiers
Learn more
What is the outlook (prognosis) for Meibomianitis?

Meibomianitis is not a vision-threatening condition. However, it may be a long-term (chronic) and recurring cause of eye irritation. Many people find the treatments frustrating because results are not often immediate. Treatment, however, will often help reduce symptoms.

When should I contact a medical professional for Meibomianitis?

Call your provider if treatment does not lead to improvement or if styes develop.

How do I prevent Meibomianitis?

Keeping your eyelids clean and treating associated skin conditions will help prevent meibomianitis.

Eye anatomy
What are the latest Meibomianitis Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
What are the Latest Advances for Meibomianitis?
Oral antibiotics for chronic blepharitis.
Tired of the same old research?
Check Latest Advances
Who are the sources who wrote this article ?

Published Date: August 18, 2020
Published By: Franklin W. Lusby, MD, ophthalmologist, Lusby Vision Institute, La Jolla, CA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Foulks GN, Lemp MA. Meibomian gland dysfunction and the evaporative eye. In: Mannis MJ, Holland EJ, eds. Cornea. 5th ed. Philadelphia, PA: Elsevier; 2022:chap 33.

Valenzuela FA, Perez VL. Mucous membrane pemphigoid. In: Mannis MJ, Holland EJ, eds. Cornea. 4th ed. Philadelphia, PA: Elsevier; 2017:chap 49.

Vasaiwala RA, Bouchard CS. Noninfectious keratitis. In: Yanoff M, Duker JS, eds. Ophthalmology. 5th ed. Philadelphia, PA: Elsevier; 2019:chap 4.17.